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Ann Arbor, Michigan; and {Department of Chemistry, Eastern Michigan University, Ypsilanti, MichiganABSTRACT A 21-residue peptide segment, LL7-27 (RKSKEKIGKEFKRIVQRIKDF), corresponding to residues 7–27 of the
only human cathelicidin antimicrobial peptide, LL37, is shown to exhibit potent activity against microbes (particularly Gram-posi-
tive bacteria) but not against erythrocytes. The structure, membrane orientation, and target membrane selectivity of LL7-27 are
characterized by differential scanning calorimetry, ﬂuorescence, circular dichroism, and NMR experiments. An anilinonaphtha-
lene-8-sulfonic acid uptake assay reveals two distinct modes of Escherichia coli outer membrane perturbation elicited by LL37
and LL7-27. The circular dichroism results show that conformational transitions are mediated by lipid-speciﬁc interactions in the
case of LL7-27, unlike LL37. It folds into an a-helical conformation upon binding to anionic (but not zwitterionic) vesicles, and also
does not induce dye leakage from zwitterionic lipid vesicles. Differential scanning calorimetry thermograms show that LL7-27 is
completely integrated with DMPC/DMPG (3:1) liposomes, but induces peptide-rich and peptide-poor domains in DMPC lipo-
somes. 15N NMR experiments on mechanically aligned lipid bilayers suggest that, like the full-length peptide LL37, the peptide
LL7-27 is oriented close to the bilayer surface, indicating a carpet-type mechanism of action for the peptide. 31P NMR spectra
obtained from POPC/POPG (3:1) bilayers containing LL7-27 show substantial disruption of the lipid bilayer structure and agree
with the peptide’s ability to induce dye leakage from POPC/POPG (3:1) vesicles. Cholesterol is shown to suppress peptide-
induced disorder in the lipid bilayer structure. These results explain the susceptibility of bacteria and the resistance of erythro-
cytes to LL7-27, and may have implications for the design of membrane-selective therapeutic agents.INTRODUCTIONCathelicidins are a family of structurally diverse AMPs that
are located at the carboxyl terminus of a 15–18 kDa highly
conserved cathepsin-L-inhibitor (cathelin)-like domain
(1,2). LL37 is the only human antimicrobial peptide in the
cathelicidin family. It is synthesized as an 18 kDa propeptide
(hCAP18) consisting of a 13.5 kDa N-terminal cathelin-like
domain and the 4.5 kDa active peptide, LL37 (Table 1), con-
sisting of the 37 C-terminal residues. LL37 is active against
both Gram-positive and Gram-negative bacteria. Several
properties of LL37 make it an excellent candidate for
research in this important area and for potential drug devel-
opment (3,4). LL37 is the only human cathelicidin antimi-
crobial peptide, and therefore it is of considerable interest
to understand how this peptide functions in detail. Unlike
many other defensins, LL37 retains a broad-spectrum bacte-
ricidal activity at physiological or elevated salt concentra-
tions—a distinct advantage for potential therapeutic usesSubmitted June 15, 2009, and accepted for publication September 29, 2009.
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0006-3495/10/01/0248/10 $2.00(5). It is devoid of disulfide bridges, allowing easier and
less costly chemical synthesis. Its high rate of microbial
killing should provide an advantage for topical applications,
since bacterial killing could be achieved before the peptide is
mechanically cleared or inactivated. LL37 has also been
shown to neutralize lipopolysaccharide activity (6). More
details on the multifunctional properties and potential phar-
maceutical applications of LL37 can be found elsewhere
(3,4).
LL37 appears to form dimeric and trimeric aggregates in
solution under experimental conditions (7) as well as in lipid
bilayers, as shown by 14N solid-state NMR studies (8), and is
significantly protected from proteolytic degradation, whereas
other native antimicrobial peptides are highly susceptible to
enzymatic degradation. The biological expression and purifi-
cation of LL37 from Escherichia coli have been reported
(9,10). Previous NMR studies on LL37 reported the high-
resolution structure in detergent micelles (11,12) and the
mechanism of membrane disruption (13,14). Recent
biophysics studies have reported membrane interactions
(15–18) and fibril formation of LL37 (19).
LL37 and a subset of peptides corresponding to different
segments of LL37 have been shown to exhibit potent lytic
activities against microbes, cancer cells, and red blood cells
(3,20). In our search for peptides with improved antimicro-
bial activity and cell selectivity, we identified a 21-residue
peptide segment corresponding to residues 7–27 of LL37
(which we call LL7-27) that exhibits membrane-selective
activity (Table 1). The structures and helical wheeldoi: 10.1016/j.bpj.2009.09.060
TABLE 1 Amino acid sequences and properties of LL37 and LL7-27
Peptide Amino acid sequence GRAVY30 Aliphatic index31
LL37 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES 0.724 89.46
LL7-27 RKSKEKIGKEFKRIVQRIKDF 1.371 69.52
Nonhemolytic Fragment of LL37 249representation of both peptides are given in Fig. 1. In this
study, we investigated the hemolytic and antimicrobial activ-
ities of LL7-27 and its ability to disrupt the outer membrane
of E. coli and to interact with model membranes that mimic
bacterial and mammalian membranes. To obtain information
on the membrane selectivity, we determined the lipid-
induced conformational transitions of the peptide using CD
experiments. Specific lipid-peptide interactions were
observed by following the phase transition behavior of
MLVs formed from a DMPC and also from DMPC/DMPG
(3:1) mixture. The peptide’s membrane orientation and
ability to permeabilize anionic model membranes mimicking
the bacterial inner membrane were studied by means of
solid-state NMR experiments. Our data from this study
suggest that the lipid-induced conformational transitions of
the peptide and its integration with anionic membrane form
the basis for the observed antimicrobial activity of LL7-27.MATERIALS AND METHODS
Materials
All phospholipids were purchased from Avanti Polar Lipids (Alabaster, AL).
Chloroform and methanol were procured from Aldrich Chemical (Milwau-
kee, WI). Naphthalene was purchased from Fisher Scientific (Pittsburgh,
PA). Buffers were prepared using water obtained from NONApure A filtra-
tion system. All protected amino acids, solvents, and reagents were
purchased from Bachem (Torrance, CA), Synthetech (Butler, NJ), Aldrich
Chemical (Milwaukee, WI), Fisher Scientific (Chicago, IL), and Protein
Technologies (Tucson, AZ). All of the chemicals were used without further
purification.
Peptide synthesis
Two peptides (LL7-27 and 15N-Val15-LL7-27) were prepared on an auto-
mated peptide synthesizer from Protein Technologies using standard solid-
phase techniques for N-a-fluorenylmethyloxycarbonyl (Fmoc)-protected
amino acids on Rink amide p-methylbenzhydrylamine resin (0.6 mmole/g).
A 20% piperidine in N,N-dimethylformamide was used for deprotection.
O-(Benzotriazol-1yl)-1,1,3,3-tetramethyluronium hexafluorophosphate wasused for coupling. Deprotection and cleavage from the resin were accom-
plished using 11 mL of a 90% trifluoroacetic acid (TFA)/10% scavenger
cocktail (anisole, thioanisole, ethanedithiol, phenol, and water). Crude
peptides were purified to homogeneity by preparative reversed-phase
high-performance liquid chromatography on a Waters instrument with a Phe-
nomenex C18 column (2.2 25.0 cm, 10 mL/min). A linear gradient of 10%
acetonitrile (0.1% TFA)/water (0.1% TFA) to 50% acetonitrile (0.1% TFA)/
water (0.1% TFA) was employed. The molecular weight of the peptide was
confirmed using mass spectrometry.
Bacterial strains and growth
Porphyromonas gingivalis (ATCC 33277) was obtained from the American
Type Culture Collection. Enterococcus faecalis cultures were a gift from
Dr. Donald B. Clewell (University of Michigan). Bacillus subtilis ATCC
6633, E. coli ATCC 8739, Staphylococcus aureus ATCC 6538, Pseudo-
monas aeruginosa ATCC 9027, Streptococcus Gordonia, Enterococcus
faecalis FA2-2, Enterococcus faecalis OG1X, and Salmonella enteritis
Typhimurium ATCC 14028 were obtained from MicroBiologics (St. Cloud,
MN). The anaerobic bacteria were maintained by weekly transfer in an
anaerobe chamber (Coy Manufacturing, Grass Lake, MI) at 37C on
PRAS Brucella agar plates (Anaerobe Systems, Morgan Hill, CA) in 10%
carbon dioxide, 5% hydrogen, and 85% nitrogen atmosphere. Broth cultures
were grown in a mixture of 50% Trypticase soy broth, 50% brain heart
infusion broth, and 5 g/L yeast extract supplemented with 5 mg/L hemin,
0.01 gm/L sodium bisulfite, and 5 mg/L vitamin K. Aerobic species were
maintained by weekly transfer on Trypicase soy agar and broth cultures
grown from individual colonies in Trypticase soy broth.
Antimicrobial assay
A doubling dilution series of peptide (100 mg/mL to 0.1 ng/mL) was added
to the wells of sterile 384-well microtiter plate (12 replicates per dilution)
and dried for ~12 h. Bacterial suspensions (10 mL, 107/mL) were added to
the wells, centrifuged briefly to collect the cells in the bottom of the wells,
and incubated at 37C for 10–40 h depending upon the rate of growth of the
bacterial species. MICs were set as the lowest concentration of the peptide at
which there was no growth above the inoculated level of bacteria (p < 0.05,
n ¼ 12).
Hemolysis assay
The hemolytic activity of the peptides was determined by the released hemo-
globin from suspensions of fresh sheep erythrocytes as absorbance atFIGURE 1 Helical wheel representations of LL37 and
LL7-27. The NMR structure of LL37 was used (11).
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TABLE 2 Antimicrobial activities of LL37 and LL7-27 against
different microbes
Bacteria (OD600 ¼ 0.002) MIC (mg/mL) LL7-27 MIC (mg/mL) LL37
E. coli ATCC 12014 0.4 0.1
P. aeruginosa ATCC 10145 100 12.5
B. subtilus ATCC 11774 0.1 0.1
S. gordonii 6.25 12.5
S. aureus 50 50
S. enterica ATCC BAA-215 50 50
E. faecalis Strain FA2-2 12.5 12.5
E. faecalis Strain OG1X 50 50
P. gingivalis Strain 33277 12.5 12.5
250 Thennarasu et al.414 nm. Red blood cells (Colorado Serum, Denver, CO) were centrifuged
and washed four times with PBS (0.15 M NaCl, 0.005 M phosphate buffer,
pH 7.4). Then 100 mL of red blood cells were added to the wells of a 96-well
plate, and 100 mL of the peptide solution (in PBS) were added to each well.
The plates were covered with an adhesive plastic sheet, incubated for 1 h at
37C, and centrifuged at 200 g for 10 min. Absorbance of the supernatants
was measured at 414 nm, and 0% and 100% hemolysis was determined in
PBS and 0.1% Triton X-100, respectively.
Outer-membrane disruption assay
The outer-membrane permeabilizing ability was investigated by means of
the ANS uptake assay, using E. coli strain BL21 (DE3). Bacterial cells
from an overnight culture were inoculated into Luria-Bertani broth medium.
Cells from the mid-log phase were centrifuged and washed with Tris buffer
(10 mM Tris, 150 mM NaCl, pH 7.4) and then resuspended in Tris buffer to
an OD600 of 0.359. A stock solution of ANS was added to 3.0 mL of the cell
suspension in a cuvette, to a final concentration of 5.75 mM. The extent of
membrane disruption was observed as a function of peptide concentration
by the increase in fluorescence intensity at ~500 nm.
Circular dichroism
SUVs were prepared as described below and used for secondary structure
analysis by means of CD experiments. An appropriate amount of lipid was
dissolved in chloroform and the clear solution was taken to dryness. Tris
buffer (10 mM Tris, 150 mM NaCl, pH 7.4) was added to dry lipid film
and subjected to vortex and sonication to obtain a clear dispersion of
SUVs. CD spectra were recorded (CDS model 62DS spectropolarimeter;
AVIV Biomedical, Lakewood, NJ) at 25C over a range of 200–250 nm using
samples with a peptide/lipid ratio of ~1:50 in a quartz cuvette (path length ¼
0.1 cm). Minor contributions from the buffer and SUVs were removed by sub-
tracting the spectra of the corresponding control samples without peptide. The
resultant spectra were normalized for path length and concentration.
Dye leakage assay
Carboxyfluorescein dye entrapped SUVs were prepared as described else-
where (21). Briefly, Tris buffer (10 mM Tris, 100 mM NaCl, pH 7.0) con-
taining 50 mM dye was added to the dry lipid film, vortexed, and sonicated.
The dye-containing vesicles were then purified by gel filtration chromatog-
raphy using a Sephadex G-75 column. Serial concentrations of peptides
were added to aliquots of vesicle suspension (50 mM lipid) in Tris buffer,
and the fluorescence emission intensity at 520 nm was recorded as a function
of time using an excitation wavelength of 490 nm. The maximum leakage
was determined by adding 0.1% Triton X-100. The steady-state fluorescence
emission spectra of the peptide-vesicle mixtures were measured on a Fluoro-
Max2 spectrofluorimeter (Jobin Yvon-Spex Instruments, Edison, NJ).
Differential scanning calorimetry
Lipid films of DMPC and DMPC/DMPG (3:1) were prepared by mixing the
lipid and peptide in a chloroform-methanol mixture in the desired molar
ratio, drying the sample under a gentle stream of nitrogen, and then placing
it under vacuum overnight to remove any residual solvent. The dried
samples were hydrated with Tris buffer (10 mM Tris, 150 mM NaCl,
pH 7.4) and then vortexed above the main phase transition temperature to
obtain MLVs. Tris buffer (10 mM Tris, 150 mM NaCl, pH 7.4) was added
to MLVs to produce a final lipid concentration of 1.0 mg/mL DMPC and
DMPC/DMPG (3:1). All buffers and samples were degassed under vacuum
for 10 min before being loaded into the Nano-DSC II calorimeter (Calorim-
etry Sciences, Provo, UT). The scan rate was 1.0C/min over a temperature
range of 5–40C. The raw data were converted to molar heat capacity using
the CPCalc program provided with the calorimeter and taking into account
the lipid concentration, molecular weight of each sample, and a partial
specific volume of 0.956 mL/g.Biophysical Journal 98(2) 248–257Mechanically aligned bilayers
Mechanically aligned POPC and POPC/POPG (3:1) bilayers were prepared
as described elsewhere (22). Briefly, 7 mg of lipids and an appropriate
amount of peptide were dissolved in a CHCl3/CH3OH (2:1) mixture. The
sample was dried under nitrogen gas and dissolved in a CHCl3/CH3OH
(2:1) mixture containing equimolar quantities of naphthalene. An aliquot
of the solution (~300 mL) was spread on thin glass plates (Paul Marienfeld
GmbH, Bad Mergentheim, Germany). The samples were dried under
vacuum at ~33C for at least 12 h to effectively remove naphthalene and
any residual organic solvents. After drying, the samples were hydrated at
93% relative humidity using saturated NH4H2PO4 solution for 3 days at
37C, after which ~2.5 mL of H2O were misted onto the surface of the
lipid-peptide film. The glass plates were stacked, wrapped with parafilm,
sealed in plastic bags (Plastic Bagmart, Marietta, GA), and then kept at
4C for 6–24 h.
Solid-state NMR experiments
All NMR spectra of mechanically aligned lipid bilayers were obtained from
a Chemagnetics/Varian Infinity 400 MHz solid-state NMR spectrometer
operating at resonance frequencies of 40.549 MHz, 161.977 MHz, and
400.1375 MHz for 15N, 31P, and 1H nuclei, respectively, using 1H/31P and
1H/15N in-house-built double-resonance, flat-coil probes. A Chemagnetics
temperature controller was used to maintain the sample temperature, and
each sample was equilibrated at 37C for at least 25 min before the experi-
ment was started. The lipid bilayers were positioned in such a way that the
bilayer normal was parallel to the external magnetic field. 15N spectra were
recorded using a 1.5 ms ramp-CP (with a 10 kHz ramp on the 1H channel)
sequence with a 1H p/2 pulse length of 3 ms, a recycle delay of 3 s, 50 kHz
CP power, and a 71 kHz TPPM decoupling of protons during acquisition.
The spectra were referenced relative to liquid ammonia (0 ppm). 31P spectra
were obtained using a spin-echo sequence with a 3ms 90 pulse width, 35 kHz
proton-decoupling radio frequency field, and a 3 s recycle delay. A typical
31P spectrum required the coaddition of ~1000 transients and was referenced
relative to 85% H3PO4 on thin glass plates (0 ppm). Data were processed
using Spinsight (Chemagnetics/Varian) software on a Sun Sparc workstation.RESULTS
Disruption of E. coli membranes
As can be seen from the MIC values given in Table 2, LL7-
27 exhibits a broad spectrum of antimicrobial activity against
Gram-negative and Gram-positive bacteria at micromolar
concentrations. As the antimicrobial activity of LL37 is
believed to stem from its ability to permeabilize bacterial
membranes, it is likely that LL7-27 also exerts its activity
by interacting with the bacterial membranes. Therefore, we
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FIGURE 2 (A) LL37- and (B) LL7-27-induced ANS binding to E. coli
membrane. Normalized fluorescence intensities are presented in both
figures. The relative fluorescence intensities of ANS (5.75 mM) in the
Nonhemolytic Fragment of LL37 251compared the abilities of LL37 and LL7-27 to disrupt the
bacterial membrane by monitoring the ANS uptake assay.
The ANS (5.75 mM) equilibrated with 3 mL E. coli cells
showed an emission maximum at ~519 nm (Fig. 2 A, trace
a). The successive addition of aliquots of LL37 to a 3 mL
cell suspension resulted in an enhancement in the fluores-
cence intensity of ANS and a shift in the emission maximum.
At 1.85 mM peptide concentration, the observed emission
maximum was ~480 nm. The blue shift in the emission
maximum and the enhancement in the fluorescence intensity
of ANS indicate that ANS relocates into a relatively less
polar environment (presumably the bacterial membrane) as
a consequence of outer-membrane disruption by LL37. On
the other hand, ANS showed a blue-shifted emission
maximum at ~495 nm when a 3.17 mM concentration of
LL7-27 was used against E. coli pretreated with 5.75 mM
ANS dye (Fig. 2 B). The enhancement in the fluorescence
intensity of ANS at the emission maximum upon addition
of the highest concentration of the peptides was ~1.5-fold (in
the case of LL37) and ~0.25-fold (in the case of LL7-27)
higher than the fluorescence intensity of ANS (5.75 mM) in
the absence of any peptides. These results suggest that
LL7-27 is a weaker membrane-disrupting agent than the lytic
peptide LL37, and that these peptides have different modes
of interaction with the bacterial membrane.
Membrane bilayer peturbation from dye leakage
and 31P NMR experiments
A number of antimicrobial peptides that strongly bind with
negatively charged vesicles have been reported to induce
leakage of vesicular contents. Because LL7-27 displayed
a modest effect in disrupting the bacterial membrane, we
studied its ability to induce dye leakage from lipid vesicles
using a fluorescence method. Carboxyfluorescein dye-
entrapped POPC/POPG (3:1) SUVs (50 mM) were suspended
in Tris buffer (pH 7.4), aliquots of peptide solutions were
added, and the kinetics of dye leakage was monitored as a
function of time. Fig. 3, A and B, show the dye leakage profile
upon addition of LL37 (up to 2.97 mM) and LL7-27 (up to
5.07 mM), respectively. As shown in Fig. 3, A and B, LL37
and LL7-27 induced significant dye leakage from POPC/
POPG (3:1) vesicles in a concentration-dependent manner.
These data clearly show that both LL37 and LL7-27 have
the ability to permeabilize negatively charged membrane,
and that LL7-27 is a weak membrane-disrupting agent.
When aliquots of LL37 and LL7-27 were added to dye-
entrapped POPC liposomes, only LL37 induced the release
of dye in a concentration-dependent manner (80% dye
leakage at P/L¼ 1:225; Fig. 3C), and LL7-27 failed to induceabsence of the peptides (trace a in both figures) were comparable in both
experiments. (A) LL37 concentrations: trace a (no peptide), b (0.37 mM),
c (0.74 mM), d (1.11 mM), e (1.48 mM), and f (1.85 mM). (B) LL7-27 concen-
trations: trace a (no peptide), b (0.63 mM), c (1.26 mM), d (1.9 mM),
e (2.53 mM), and f (3.17 mM).
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FIGURE 3 (A) LL37- and (B) LL7-27-induced carboxy-
fluorescene dye leakage from POPC/POPG (3:1) vesicles
(50 mM). (A) LL37 concentrations: trace a (0.15 mM),
b (0.37 mM), c (0.74 mM), d (1.11 mM), e (1.48 mM),
f (2.26 mM), and g (2.97 mM). (B) LL7-27 concentrations:
trace a (0.253mM), b (0.633mM), c (1.26 mM), d (2.53 mM),
e (3.8 mM), and f (5.07 mM). (C) LL37- and (D) LL7-27-
induced carboxyfluorescene dye leakage from POPC vesi-
cles (50 mM). (C) LL37 concentrations: trace a (0.074 mM),
b (0.148mM), c (0.222mM), d (0.329mM), and e (0.37 mM).
(D) LL7-27 concentrations: trace a (0.63mM), b (2.52mM), c
(3.78 mM), d (5.04 mM), and e (6.3 mM).
252 Thennarasu et al.any significant dye release even at P/L¼ 1:8 (Fig. 3 D). Only
basal-level fluorescence (~20%) was observed for POPC
MLVs containing LL7-27 (Fig. 3 D), which is typical in
dye leakage experiments due to stirring and slight changes
in pH, and it was not subtracted in our data.
Previous solid-state NMR studies reported the LL37 struc-
ture and its interaction with various types of membrane
(13,14). In this study, to further understand LL7-27’s ability
to disrupt the bacterial inner membrane, we performed 31P
NMR experiments on mechanically aligned POPC and
POPC/POPG (3:1) bilayers. A single narrow line at the
higher frequency (or the parallel) edge of the 31P chemical
shift powder pattern spectrum was observed, as reported in
our earlier publications (see Fig. 4 A; data not shown for
pure POPC) (13). No significant changes were observed
for POPC bilayers containing up to 5 mol of LL7-27, which
is consistent with its inability to induce dye leakage from
POPC liposomes. On the other hand, when POPC/POPG
(3:1) bilayers were incorporated with 3 mol % LL7-27, the
linewidth of the peak increased significantly (Fig. 4 B), sug-
gesting that the peptide binding to lipid bilayers affects the
conformation of the lipid headgroups, which is in good
agreement with the dye leakage from POPC/POPG (3:1)
vesicles. Of interest, the inclusion of 3 mol % LL7-27 in
POPC/POPG (3:1) bilayers containing 15 mol % cholesterolBiophysical Journal 98(2) 248–257resulted in the spectrum shown in Fig. 4 C, which indicates
that cholesterol inhibits the peptide-induced structural
disorder in lipid bilayers.Secondary structure
Since the modes of interaction of LL7-27 with POPC and
POPC/POPG (3:1) membranes are distinct, we studied the
secondary structure of LL37 and LL7-27 in the presence of
POPC and POPC/POPG (3:1) liposomes. The CD spectrum
of LL37 in aqueous buffer (pH 7.4) displayed two broad
minima at ~206 and ~222 nm, indicating the existence of
a helical structure (Fig. 5 A), in good agreement with
a previous NMR study of LL37 in solution. Upon the addition
of POPC or POPC/POPG (3:1) liposomes, LL37 showed rela-
tively sharp negative minima at 209 and 222 nm, suggesting
a conformational transition into a regular a-helical structure.
The calculated fractional helicity (~40%) is in good agree-
ment with the reported NMR structures from detergent
micelles or lipid bilayers (11). On the other hand, the CD spec-
trum of LL7-27 in aqueous buffer exhibited a negative
minimum at ~203 nm, suggesting a random coil conformation
(Fig. 5 B). In the presence of POPC/POPG (3:1) SUVs, the
peptide showed a negative minimum at ~208 nm and another
minimum at ~222 nm, indicating the formation of a-helical
-40-200204060
31P Chemical Shift (ppm) 
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C
FIGURE 4 Phosphorus-31 chemical-shift spectra of mechanically aligned
lipid bilayers at 37C: (A) POPC/POPG (3:1), (B) POPC/POPG (3:1)
containing 3 mol % of LL7-27, and (C) POPC/POPG (3:1) containing
3 mol % of LL7-27 and 15 mol % of cholesterol.
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Nonhemolytic Fragment of LL37 253conformation; the fractional helicity of the peptide was calcu-
lated to be ~25%. Of interest, the addition of POPC liposomes
to the LL7-27 solution did not induce any observable transi-
tion in the conformation of the peptide; the CD profiles of
LL7-27 in buffer and in the presence of POPC vesicles were
comparable. This might suggest that the peptide does not
bind to the zwitterionic POPC membrane, or it binds weakly
and the membrane-induced structural changes in the peptide
are minimal. From the CD data, it is clear that LL7-27, unlike
its parent peptide LL37, interacts distinctly with anionic and
neutral lipid membranes.
Effect of lipid-LL7-27 interactions on the main
phase transition from DSC experiments
To further understand LL7-27-membrane interactions, we
investigated the effect of the peptide on the thermotrophic
phase transition behavior of multilamellar lipid vesicles.
DSC themograms were obtained from pure DMPC and
DMPC/DMPG (3:1) MLVs, and in the presence of different
amounts of LL7-27. The effect of LL7-27 on the phase tran-sition of negatively charged DMPC/DMPG (3:1) liposomes
is shown in Fig. 6 A. The DMPC/DMPG (3:1) MLVs
showed a pretransition at 16C and the main transition atBiophysical Journal 98(2) 248–257
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254 Thennarasu et al.24.8C. However, when 0.258 mol % of LL7-27 was incor-
porated, a reduction in enthalpy of both the pretransition and
main transition was observed. The incorporation of
increasing quantities of LL7-27 produced a broadening of
the phase transition curves as well as a reduction in the
main phase transition enthalpy, suggesting a homogeneous
intergration of LL7-27 with DMPC/DMPG (3:1) liposomes.
The enthalpies calculated for pure DMPC and DMPC
incorporated with 0.258 mol % of LL7-27 are comparable,
as the main phase transition behavior of DMPC MLVs was
only marginally influenced by the presence of LL7-27
(Fig. 6 B). These data suggest that there is very little effect
on the gel-to-liquid-crystalline (La) phase transition temper-
ature at ~24C. Similarly, the pretransition arising from the
lamellar gel (Lb
0) to lamellar rippled gel (Pb0) phase is also
not significantly affected. The few changes in the transition
temperature (Tm) indicate that the peptide does not alter the
packing of the hydrocarbon chains of DMPC in the gel
and liquid-crystalline states. Consequently, the incorporation
of progressive amounts of LL7-27 resulted in the abolition of
the pretransition and the emergence of a two-component
main transition. The relative contributions of the high-
temperature component of the main transition also became
more prominent at higher peptide concentrations. The sharp
component at 24C is attributed to the hydrocarbon chain
melting of the peptide-poor lipid domain, whereas the broad
high-temperature component is believed to arise from the
peptide-rich lipid domain. The consistent decrease in the
Tm and enthalpy of the sharp low-temperature component
may be attributed to a decreasing size of the peptide-poor
domain as the concentration of peptide is increased. In
summary, these results indicate that LL7-27 does not inte-
grate homogeneously with DMPC membrane and is located
at the membrane-water interface, as revealed by the 15N
NMR experiments described below.Temperature (oC)
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FIGURE 6 DSC thermograms showing the effects of LL7-27 on the
phase transition of (A) DMPC/DMPG (3:1) (MLVs, 1 mg/mL) and
(B) DMPC (MLVs, 1 mg/mL) consisting of various peptide concentrations :
a (4.136 mol %; the bottom most trace); b (2.068 mol %); c (1.034 mol %);
d (0.517 mol %); e (0.258 mol %); f (no peptide).Membrane orientation of LL7-27 from solid-state
NMR experiments
It is important to determine the membrane orientation of
LL7-27 to understand the mechanism of membrane disrup-
tion by the peptide (23). Solid-state NMR spectroscopy of
aligned samples is a unique approach to determine the
membrane orientation of the peptide, as demonstrated in
previous studies on membrane-associated peptides and
proteins (24–27). A two-dimensional PISEMA (28,29) spec-
trum correlating the 15N chemical shift and 15N-1H dipolar
coupling frequencies associated with the amide site of the
mechanically aligned POPC/POPG (3:1) bilayers containing
2 mol % 15N-Val15-LL7-27 is given in Fig. 7. The presence
of a single peak corresponding to a 85 ppm 15N chemical
shift and a 4.0 kHz 15N-1H dipolar coupling suggests that
the LL7-27 peptide is oriented with its helix axis perpendic-
ular to the bilayer normal. Since the peptide forms an amphi-
pathic helical structure in a membrane environment andBiophysical Journal 98(2) 248–257
1 H
-1
5 N
 D
ip
ol
ar
 C
ou
pl
in
g 
(k
H
z)
2.0
4.0
6.0
15N Chemical Shift (ppm)
507090100
FIGURE 7 Nitrogen-15 chemical-shift spectrum of mechanically aligned
POPC/POPG (3:1) lipid bilayers containing 3 mol % of LL7-27 at 37C.
The bilayer normal of the sample was set along the external magnetic field
direction.
Nonhemolytic Fragment of LL37 255perturbs the lipid headgroup region, as revealed by 13P NMR
results (Fig. 4), it is very likely that it is located close to the
lipid bilayer surface and near the phosphate headgroup
region of lipids. A model developed based on the NMR
results presented in this study and also using the NMR struc-
ture of LL37 peptide is shown in Fig. 8.DISCUSSION
The broad spectrum of antimicrobial properties exhibited by
the only human cathelicidin antimicrobial peptide, LL37,
make it an attractive candidate for the design of potent peptide
antibiotic compounds to potentially overcome the problem of
increasing bacterial resistance. Previous NMR studies have
reported its high-resolution three-dimensional structure
(11), membrane orientation (13), and modes of membrane
permeation from model membranes to elucidate the antimi-
crobial and other biological properties of this intriguing
molecule (3,14). Since the formation of a helical structure in
solution as well as in membrane has been thought to play an
important role in the functions of LL37, it is imperative to
investigate the property of a peptide segment that comprises
a part of the highly helical region (residues 15–31) of LL37.The deletion of N- and C-terminal segments of LL37 would
leave LL7-27 with a reduced hydrophobicity and a-helical
propensity as compared to LL37. The altered hydrophobicity
and helix propensity might minimize or eliminate the undesir-
able hemolytic activity observed in the case of LL37. With
a net charge of þ8 at neutral pH, and an aliphatic index of
69.52 (see Table 1) (30,31), LL7-27 can be expected to retain
the broad spectrum of antimicrobial property of the parent
peptide LL37. These 21 residues with a moderate a-helical
propensity can fold, in principle, into ~6 helical turns,
providing a ~31.5 A˚ long a-helix that is sufficient to span
the membrane bilayer. In this study, we investigated the anti-
microbial and membrane permeation properties of LL7-27
and compared them with those of the parent peptide LL37.
LL7-27 exhibits a broad spectrum of antimicrobial
activities, but is more effective against
Gram-positive bacteria
The MIC values reported in Table 2 indicate that LL7-27
inhibits the growth of several of the bacterial strains exam-
ined in this study and is slightly less potent than LL37
against Gram-negative bacteria. The pronounced activity of
LL37 observed in ANS uptake by E. Coli cells (Fig. 2 A)
and in dye leakage from POPC/POPG (3:1) liposomes
(Fig. 3 B) mimicking the bacterial inner membrane suggest
that LL37 is potent in disrupting both the inner and outer
membranes of bacteria. This property is well correlated
with the nonselective cell-lytic activities of LL37 given in
Table 2. On the other hand, LL7-27 exhibits a strong disrup-
tion of the bacterial inner membrane (Fig. 3 A) but a weak
disruption of the outer membrane of E. coli (Fig. 2 B). These
membrane-disrupting properties are in good agreement with
low MIC values for both peptides against Gram-positive
bacteria and high MIC values for LL7-27 in the case of
Gram-negative bacteria. For example, the MIC values against
Gram-positive bacteria B. subtilus, S. aureus, and E. faecalis
are the same for both peptides under the conditions used in this
study. However, the MIC values for LL37 against Gram-
negative bacteria E. coli and P. aeruginosa are considerably
smaller than those of LL7-27. These results suggest that
residues 1–6 and 28–37 of LL37 may have a role in disruptingFIGURE 8 Orientation of LL37 and LL7-27 in phospho-
lipid bilayers depicting a carpet-type mechanism of activity.
The model was constructed from solid-state NMR experi-
mental results.
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nonselective cell-lytic activities of LL37. It is interesting to
note that under the experimental conditions used to observe
the antimicrobial properties, only LL37 (and not LL7-27)
showed hemolytic activity. The selectivity displayed by
LL7-27 against bacteria and not against human erythrocytes
is intriguing and suggests that the mechanism of cell-peptide
interactions should be explored at the molecular level.
Structured LL7-27 selectively permeates anionic
membranes
The difference in the membrane composition of bacterial and
mammalian cell membranes has been thought to play a major
role in the selectivity of antimicrobial peptides. For example,
the presence of cholesterol in human erythrocyte membrane
imparts rigidity to the membrane bilayer and confers resis-
tance to peptide-induced membrane permeation, as shown
by deuterium NMR studies on pardaxin (32) and LL37
(14). Conversely, the presence of anionic lipids in bacterial
membrane enables selective interaction with cationic
AMPs (33,34). In this study, we determined the role of
anionic lipids in the membrane permeating effects of LL7-
27 using DSC, CD, and dye leakage experiments on zwitter-
ionic POPC as a model mammalian membrane, and anionic
POPC/POPG (3:1) as a model bacterial membrane. The
selective interaction of the peptide with anionic membrane
was confirmed by the complete integration of LL7-27 into
DMPC/DMPG (3:1) membrane, as revealed by DSC thermo-
grams (Fig. 6 A). The formation of peptide-rich domains
(Fig. 6 B) in DMPC MLVs can only be explained by
a lipid-induced peptide aggregation process. Because the
homogeneous integration of the peptide in anionic lipid bila-
yers and the peptide aggregation in zwitterionic lipid bilayers
are two distinct physical processes, the lipid-induced confor-
mational changes in the peptide should also be distinctly
different. This hypothesis is corroborated by the random
coil to a-helical transition of LL7-27 in the presence of
anionic POPC/POPG (3:1) lipids (Fig. 5 B). This hypothesis
gains support from the 31P NMR data that reveal the peptide-
induced disorder only in anionic lipid bilayers (Fig. 4 B).
This proposition also explains our observation of peptide-
induced leakage from anionic liposomes and not from zwit-
terionic liposomes (Fig. 3, B and D). Therefore, it appears
that the electrostatic interactions between the cationic
LL7-27 and anionic lipids lead to the segregation of cationic
and hydrophobic residues along the nascent helix. Such
a helix would be amphipathic and exert a profound effect
on anionic membranes as compared to the weak interactions
of LL7-27 with zwitterionic membranes.
Carpet-type mechanism of membrane disruption
by LL7-27
The presence of a single peak in the low-frequency region
(85 ppm) in the 15N chemical-shift frequency scale of theBiophysical Journal 98(2) 248–257two-dimensional PISEMA spectrum with a 4 kHz dipolar
coupling value suggests that the helix axis of the peptide is
nearly perpendicular to the bilayer normal (Fig. 7). Since
these NMR parameters are similar to values previously re-
ported for LL37 (13), the membrane orientations of these
two peptides are likely to be similar, at least in the helical
regions of these peptides. The peptide-induced disorder
measured by 31P chemical-shift spectra (Fig. 4 B) suggests
that the cationic peptide should have strong interactions
with anionic lipids in the lipid headgroup region of the
bilayer. These results rule out the possibility of a transmem-
brane orientation and any barrel-stave-like, pore-forming
mechanism of membrane disruption within the concentra-
tions investigated in this study. Therefore, the peptide is
likely to exert its activity via a carpet-type mechanism, as
in the case of the parent peptide LL37, and at higher peptide
concentrations may lead to either toroidal-pore formation
and/or micellization of the membrane, as has been reported
for the parent peptide LL37. Solid-state NMR and other
studies have revealed the oligomeric nature of LL37 in
both solution and membranes owing to the high aliphatic
index (89.46) and a-helical propensity of the peptide. On
the other hand, the unstructured LL7-27 could be a monomer
in solution. Its low aliphatic index (69.52) and lack of ability
to oligomerize in solution may form the basis for the
peptide’s inability to permeabilize zwitterionic POPC and
human erythrocyte membranes.
In conclusion, we have identified a 21-residue nonhemo-
lytic peptide fragment of LL37 that retains a broad spectrum
of antimicrobial activity and exhibits significantly more
potent activities against Gram-positive compared to Gram-
negative bacteria. Using liposome assays and CD spectros-
copy, we have shown that lipid-induced secondary structure
formation is one of the initial steps involved in membrane-
selective binding and permeabilization. The results of 15N
NMR experiments on mechanically aligned lipid bilayers
containing a 15N-labeled LL7-27 provide evidence for the
membrane surface orientation of the peptide, which may
suggest a ‘‘carpet-type mechanism’’ of membrane permea-
bilization. Our results also suggest that residues 1–6 and
28–37 in the parent peptide LL37 may have a role in the
nonselective lytic activity of LL37, as well as in lipopoly-
saccharide detoxification. Further efforts to improve
membrane selectivity and binding affinity could yield
peptides with higher therapeutic indices. We also believe
that the results reported in this study, which demonstrate
several similarities and differences between LL7-27 and
LL37, may provide insights into the in vivo activities of
LL37.
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